BioNexus Gene Lab Corp. (BGLC)
NASDAQ: BGLC · Real-Time Price · USD
0.2501
-0.0491 (-16.41%)
At close: Mar 28, 2025, 4:00 PM
0.2497
-0.0004 (-0.17%)
Pre-market: Mar 31, 2025, 8:06 AM EDT
BioNexus Gene Lab Market Cap
BioNexus Gene Lab has a market cap or net worth of $4.49 million as of March 31, 2025. Its market cap has decreased by -64.29% in one year.
Market Cap
4.49M
Enterprise Value
601.64K
1-Year Change
-64.29%
Ranking
Category
Stock Price
$0.25
Market Cap Chart
Since September 16, 2020, BioNexus Gene Lab's market cap has decreased from $42.12M to $4.49M, a decrease of -89.33%. That is a compound annual growth rate of -38.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 4.49M | -10.58% |
| Dec 31, 2024 | 5.03M | -46.33% |
| Dec 29, 2023 | 9.36M | -94.33% |
| Dec 30, 2022 | 165.03M | -54.75% |
| Dec 31, 2021 | 364.69M | 54.35% |
| Dec 31, 2020 | 236.28M | 460.98% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Linde | 219.95B |
| BHP Group | 127.02B |
| Rio Tinto Group | 106.32B |
| The Sherwin-Williams Company | 87.05B |
| Southern Copper | 77.39B |
| Ecolab | 71.78B |
| Air Products and Chemicals | 65.82B |
| CRH plc | 61.55B |